A total of three medical fee revisions were made in Japan between 2012 and 2018 to address the issue of proper prescription of sleeping pills, which has become a major international problem. This was clarified by research by Professor Kazuo Mishima of the Graduate School of Science and Engineering, and Lecturer Masahiro Takeshima of Akita University Hospital.
According to Akita University, the research group used medical receipt data from the Japan Medical Information Center to revise medical fees for long-term prescription of sleeping pills for 2012 patients who were prescribed sleeping pills for the first time in 2016, 2018, and 18. and the effects of new sleeping pills.
As a result, the revision of medical fees for the purpose of proper use of sleeping pills did not have a significant effect on the improvement of long-term prescriptions.Among the new sleep drugs that are highly safe and non-addictive, melatonin receptor agonists did not find a significant relationship with short-term prescriptions, but starting insomnia treatment with orexin receptor antagonists led to short-term prescriptions. I knew there was
Multidrug use of sleeping pills and long-term prescription of addictive benzodiazepine receptor agonists are internationally regarded as problems.The government has revised medical fees to promote proper prescription of sleeping pills, but the effects have not been verified.During this period, new non-addictive drugs also appeared on the market, and although it was suggested that they might correct long-term use, this effect had not been verified.The research group needs further research because the severity of insomnia symptoms was not taken into account in this study.
